On the stock market since 2019, it operates in the world of health and science. It has 1,178 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Average growth of 7% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly above the class average — a step short of the very top.
Clearly above the class average — a step short of the very top.
The price isn’t cheap next to earnings — that’s why this grade sits in the middle.
The stock has been running stronger than the market lately.
No real weak spot in any of the five subjects — a balanced report card.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Executive Buying: The trades send no strong signal of confidence.
An investor who bought at the very peak is down 67% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The company sells $642.8M a year; the problem isn’t sales — it’s costs running above that number.
There is $523.4M in the vault; even if every debt were paid off, $365.7M would remain.
A loss of $43.5M against $642.8M in annual sales.
This stock swings about 2 times as much as the market average. Big rallies — and big drops — can both happen fast.
The stock trades 24% above the average analyst price target.
On our five-subject report card, TXG sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: TXG has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.